Skip To Main Content
Natán Ponieman on Muck Rack

Natán Ponieman

(He/Him)
  • Freelance Creative Writer and Communications Consultant, Freelance
United States
As seen in: Forbes, MSN, MSN Singapore, Markets Insider, Aol, Yahoo Finance, Yahoo Finance Singapore, Entrepreneur, Green Entrepreneur, Flipboard and
Writer/Journalist. Biotech, macroeconomics, finance. Features Writer @Benzinga | @Forbes contributor Bylines: Business Insider, Entrepreneur, Yahoo Finance
Back to Natán Ponieman’s profile

Natán Ponieman’s Journalist Portfolio

View as a grid

Is Mysticism Becoming A Problem For Psychedelic Medicine?

Is Mysticism Becoming A Problem For Psychedelic Medicine?

Forbes — "Did you feel that 'all is One'?" "Did you experience something profoundly sacred and holy?" "Did you feel as if you were outside time and space?" While these questions might sound best fit for a late-night campfire, they're actually part of the toolkit used by researchers to understand the experiences of patients undergoing treatment with psychedelic drugs.
Who shared?

New Coalition Seeks To Reschedule 'Magic Mushrooms' Under International Law

New Coalition Seeks To Reschedule 'Magic Mushrooms' Under International Law

Forbes — A new global coalition is looking to remove international restrictions on the research and medical use of psilocybin, the active ingredient in "magic mushrooms." As the evidence behind the therapeutic potential of psilocybin in the treatment of several mental health indications becomes harder to ignore, a number of psychedelics research and advocacy institutions from around the globe are joining forces to launch the International Therapeutic Psilocybin Rescheduling Initiative.
Who shared?

How Science Is Making Sense Of The Mystical Experience In Psychedelic Medicine

How Science Is Making Sense Of The Mystical Experience In Psychedelic Medicine

Forbes — Science and spirituality have long been deemed two worlds apart. But what happens when mysticism becomes part of a mechanism of action in a medical treatment?
Who shared?

Mike Tyson Believes In The Power Of Psychedelic Drugs-And He's Putting His Money Where His Mouth ...

Mike Tyson Believes In The Power Of Psychedelic Drugs-And He's Putting His Money Where His Mouth ...

Forbes — Mike Tyson has found peace in psychedelic medicine and now he wants to share that message with the world. Universally recognized as one of the greatest heavyweight boxers in history -as well as one of the highest-paid athletes of all time- Tyson is joining the growing list of celebrities advocating for the therapeutic use of psychedelics like "magic mushrooms" and LSD.
Who shared?

Can A Genetic Test Prevent Risk In Psychedelic Therapy? These Companies Are Betting On It

Can A Genetic Test Prevent Risk In Psychedelic Therapy? These Companies Are Betting On It

Forbes — Psychedelics are making their way back into western society. The "Psychedelic Renaissance" is bringing a promising set of tools for dealing with an alarmingly increasing wave of mental health disorders. However, all drugs carry certain risks and psychedelics are not the exception.
Who shared?

Cannabis Strain Names Are Meaningless: What Is The Industry Doing About It?

Cannabis Strain Names Are Meaningless: What Is The Industry Doing About It?

Yahoo Finance — A spectre is haunting the cannabis industry: strain names.Blue Dream, Sour Diesel, Girl Scout Cookies -- these names came up as informal ways of identifying types of cannabis in the black market era, when growers and producers had little access to scientific-grade lab testing.Today, however, strain names
Who shared?

Psychedelic Companies Looking To Identify 'Functional Mushrooms'

Psychedelic Companies Looking To Identify 'Functional Mushrooms'

Green Entrepreneur — In recent years mushrooms left their dark, hidden habitats to jump into the spotlight of consumer markets. A hunger for natural foods and wellness products propelled consumers to explore the realm of fungi as a source of nutrition and wellness, as well as a means to achieving physical and mental optimization.
Who shared?

Amanita Muscaria: A Legal Psychoactive Mushroom With Potential Therapeutic Effects

Amanita Muscaria: A Legal Psychoactive Mushroom With Potential Therapeutic Effects

Benzinga — Amanita Muscaria is an understudied species of psychoactive mushroom that's as commonplace as it is misunderstood. The iconic red-capped, white-dotted toadstool represents the archetypal idea of a mushroom in most people's minds, yet few are aware of its therapeutic potential as a psychoactive fungus.
Who shared?

Is Ketamine A Psychedelic? Depends On Who You Ask

Is Ketamine A Psychedelic? Depends On Who You Ask

Benzinga — Ketamine, an FDA-approved anesthetic drug, has recently become the star of the psychedelic medicine movement. As psychedelics like psilocybin and MDMA draw closer to FDA approval for the treatment of a variety of mental health indications, ketamine is paving the way for the development of a country-wide industry around psychedelics-assisted psychotherapy.
Who shared?

Why Are Psychedelics And Mining Companies Merging In Canada? | Benzinga

Why Are Psychedelics And Mining Companies Merging In Canada? | Benzinga

Benzinga — Since the first psychedelic companies went public in March, an array of other psychedelic start-ups followed along in a trend that can now be safely referred to as the "Psychedelic Rush." In the last two months, at least five different psychedelics companies announced plans to go public in Canada, including Cybin Corp., Entheon Biomedical, Novamind Ventures, Silo Wellness and Havn Life Sciences.
Who shared?

How Psychedelics Without Hallucinogenic Effects Could Revolutionize Psychiatry

How Psychedelics Without Hallucinogenic Effects Could Revolutionize Psychiatry

Benzinga — A new study published in the peer-review journal Cell looks at a novel compound capable of providing some of the therapeutic properties of psychedelics without hallucinations. The paper, co-authored by Delix Therapeutics co-founder and chief scientific officer David Olson, Ph.D., posits that the novel molecule - baptized "DLX-1" - may have the potential to produce some of the antidepressant effects of classic psychedelics without altering one's perception or producing a mystical experience.
Who shared?

Country's First Psychedelics Hotline Offers Counseling For People 'On A Trip'

Country's First Psychedelics Hotline Offers Counseling For People 'On A Trip'

Forbes — Wednesday marks an important date in the history of the ongoing "psychedelics renaissance." Starting now, anyone going through a tough psychedelic experience can reach the Fireside Project's Psychedelic Peer Support Line to receive free counseling and guidance from trained facilitators.
Who shared?

Is Cannabis Against Your Religion? | Leafly

Is Cannabis Against Your Religion? | Leafly

Leafly — Is consuming cannabis a sin, haram, not kosher? For many, it's a serious question. In the Judaic tradition, scholars still debate the question of whether God meant Moses to use cannabis as part of an anointing oil when he spoke of a plant called kaneh-bosem, in Exodus 30:22-30 .
Who shared?

5 Drivers Of The Correlated Growth Of Cannabis, Herbal Medicine

5 Drivers Of The Correlated Growth Of Cannabis, Herbal Medicine

Green Entrepreneur — In the past 20 years, cannabis went from an illegal substance to a $1-billion industry with virtually unlimited growth potential. Legal cannabis sales reached $10.3 billion in 2018, according to New Frontier Data, a cannabis research firm.
Who shared?

The Keys To Understanding Psilocybin's Medical Value, Market Potential

The Keys To Understanding Psilocybin's Medical Value, Market Potential

Benzinga — With a growing public acceptance of cannabis in society, there's a natural instinct to wonder about the possible health benefits and market potential of other still-illegal substances. "To me, all the psychedelic stuff, it's just prohibition 2.0," Bruce Linton, cannabis entrepreneur and former CEO of Canopy Growth Corp (NYSE: CGC), said in a recent conversation with Benzinga.
Who shared?

Understanding The Psilocybin Supply Chain: Every Production Method Explained | Benzinga

Understanding The Psilocybin Supply Chain: Every Production Method Explained | Benzinga

Benzinga — Psilocybin is known as the active compound in so-called "magic mushrooms", yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the difference between the current available means of obtaining psilocybin.
Who shared?

How Are Psychedelics Companies Earning Revenue Before Legalization?

How Are Psychedelics Companies Earning Revenue Before Legalization?

microdose.buzz — Although the future seems grand for the industry, it might be sensible to remember that most psychedelics companies today work under business models based on the forthcoming approval of some form of psychedelics-based therapy, which today is still a projection.
Who shared?

We Visited Some Cannabis Grows In Colombia To Figure Out If The Hype Is Real

We Visited Some Cannabis Grows In Colombia To Figure Out If The Hype Is Real

High Times — If you've been keeping up with the state of the international cannabis industry, then you've probably heard of Colombia being poised as the next major hub for cannabis exports.
Who shared?

Bruce Linton Talks Psychedelics Investments, Microdosing And LSD: 'The Therapeutic Potential Of P...

Bruce Linton Talks Psychedelics Investments, Microdosing And LSD: 'The Therapeutic Potential Of P...

Benzinga — Earlier this year, Canopy Growth (NYSE: CGC) co-founder and former CEO Bruce Linton invested in a neuropharmaceutical company, Mind Medicine Inc. MindMed is a psychedelic research company that's developing non-hallucinogenic medicine from psychedelic sources. The company has also welcomed Linton to its board of directors.
Who shared?

Re-Inventing the "Pothead" (Who Uses Cannabis These Days, Anyway?) | Cannabis Culture

Re-Inventing the "Pothead" (Who Uses Cannabis These Days, Anyway?) | Cannabis Culture

Cannabis Culture — CANNABIS CULTURE - Short answer: nearly everyone, with more converts everyday. Cannabis, now "legal" in many jurisdictions, is becoming an accepted therapeutic and recreational alternative. Senior citizens now represent the fastest growing demographic of cannabis user.
Who shared?

From AI to Machine Learning: How These Tech Platforms are Pushing Cannabis into the Future

From AI to Machine Learning: How These Tech Platforms are Pushing Cannabis into the Future

Civilized — Today's cannabis industry can best be described as pioneering . No word is a better fit to describe the spirit of a now-booming industry that's had to fight its way to legality through decades of activism and self-determination.
Who shared?

Off-Label Ketamine, Spravato and the Future of Ketamine Treatment for Depression | Microdose

Off-Label Ketamine, Spravato and the Future of Ketamine Treatment for Depression | Microdose

microdose.buzz — RelatedPosts Groundbreaking MDMA Study by Numinus Gets Greenlighted by Health Canada Can Psychedelics Be Used As a Preventative for Mental Illness? Braxia Reports Promising Results for In-House Study of IV Ketamine on Ultra Resistant Depression Ketamine, a dissociative drug first synthesized as an anesthetic, is now becoming increasingly used by psychiatrists as a rapid-acting antidepressant.
Who shared?

How Cannabis Legalization Became So Popular Amid Regressive Global Politics

How Cannabis Legalization Became So Popular Amid Regressive Global Politics

Civilized — In just a few years, cannabis legalization has taken the world by storm. Long-time activists, advocates and enthusiasts are seeing their decades-long dream come to life, as today's daily victories shape tomorrow's global cannabis scene.
Who shared?

The Move To Keep Information On Weed Public And Patent-Free

The Move To Keep Information On Weed Public And Patent-Free

Green Rush Daily — Patents came to be as a way to protect the rights of those working with discoveries and inventions, thus stimulating creativity, innovation and progress in a market-dominated economy. However, the ability for one company to own the rights of a specific intangible idea (or in this case, a plant's variety), has led to considerable controversy in recent history.
Who shared?
Show More